Neltependocel

N/A

Report date: 2026/03/21 20:00:21

Base Information

Drug NameNeltependocel
Drug Alias NameHuman corneal endothelial cell therapy (Aurion Biotech)AURN-001AURN001HCEC-1
ClassificationCell and gene therapy > Cell therapy > Source of cells > Cornea-derivedCell and gene therapy > Cell therapy > Somatic cell > Corneal endothelial cell therapyCell and gene therapy > Cell therapy > Donor > Allogeneic
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsSexual Dysfunction, PhysiologicalKeratitisCorneal Edema +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesEl Salvador
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAurion Biotech
China Registration ClassN/A

Develop Information

Active CompaniesAurion Biotech
Inactive CompaniesN/A
Active IndicationsSexual Dysfunction, PhysiologicalKeratitisCorneal Edema +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A